Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1954 2
1956 1
1957 2
1965 1
1967 1
1969 2
1970 2
1971 2
1973 3
1974 1
1975 6
1976 11
1977 18
1978 18
1979 24
1980 38
1981 28
1982 32
1983 32
1984 43
1985 39
1986 45
1987 44
1988 43
1989 48
1990 52
1991 66
1992 71
1993 65
1994 93
1995 71
1996 71
1997 68
1998 56
1999 55
2000 54
2001 50
2002 52
2003 44
2004 31
2005 24
2006 26
2007 18
2008 17
2009 13
2010 13
2011 17
2012 17
2013 9
2014 12
2015 8
2016 7
2017 9
2018 7
2019 10
2020 3
2021 4
2022 11
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

1,588 results

Results by year

Filters applied: . Clear all
Page 1
Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections.
Perry CM, Markham A. Perry CM, et al. Drugs. 1999 May;57(5):805-43. doi: 10.2165/00003495-199957050-00017. Drugs. 1999. PMID: 10353303 Review.
Combination regimens of piperacillin/tazobactam plus an aminoglycoside are used to treat patients with severe nosocomial (hospital-acquired) infections. In clinical trials, piperacillin/tazobactam was significantly more effective than ticarcillin/clavulanic acid in terms o …
Combination regimens of piperacillin/tazobactam plus an aminoglycoside are used to treat patients with severe nosocomial (hospital-acquired) …
Granulocyte transfusion therapy.
Marfin AA, Price TH. Marfin AA, et al. J Intensive Care Med. 2015 Feb;30(2):79-88. doi: 10.1177/0885066613498045. Epub 2013 Aug 5. J Intensive Care Med. 2015. PMID: 23920161 Review.
The cells appear to function normally by a variety of in vitro and in vivo tests. Clinical benefit, as defined by survival or clearance of infection, has not been definitively determined. Results of an ongoing randomized controlled clinical trial shoul …
The cells appear to function normally by a variety of in vitro and in vivo tests. Clinical benefit, as defined by survival or clearan …
Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study.
Bell J, Brady MF, Young RC, Lage J, Walker JL, Look KY, Rose GS, Spirtos NM; Gynecologic Oncology Group. Bell J, et al. Gynecol Oncol. 2006 Sep;102(3):432-9. doi: 10.1016/j.ygyno.2006.06.013. Epub 2006 Jul 24. Gynecol Oncol. 2006. PMID: 16860852 Clinical Trial.
Recurrence was any clinical or radiological evidence of new tumor. RESULTS: Of 457 patients, 427 (93%) were histologically and medically eligible. ...Grade 3 or 4 neurotoxicity occurred in 4/211 (2%) and 24/212 (11%) treated patients on the 3- and 6-cycle regimens, respect …
Recurrence was any clinical or radiological evidence of new tumor. RESULTS: Of 457 patients, 427 (93%) were histologically and medica …
Fludarabine: a review.
Hood MA, Finley RS. Hood MA, et al. DICP. 1991 May;25(5):518-24. doi: 10.1177/106002809102500512. DICP. 1991. PMID: 2068837 Review.
Unfortunately, the doses required to achieve adequate response in the acute leukemias (greater than 75 mg/m2) were above the maximum tolerated dose, resulting in intolerable granulocytopenia, thrombocytopenia, and a life-threatening neurotoxic syndrome. ...
Unfortunately, the doses required to achieve adequate response in the acute leukemias (greater than 75 mg/m2) were above the maximum tolerat …
Cyanamide-induced granulocytopenia.
Ajima M, Usuki K, Igarashi A, Okazaki R, Hamano K, Urabe A, Totsuka Y. Ajima M, et al. Intern Med. 1997 Sep;36(9):640-2. doi: 10.2169/internalmedicine.36.640. Intern Med. 1997. PMID: 9313109 Free article.
We report a 64-year-old male with granulocytopenia and dermatitis due to cyanamide treatment. We administered cyanamide for alcoholism. ...To our knowledge, this is the first report of a case with granulocytopenia induced by cyanamide....
We report a 64-year-old male with granulocytopenia and dermatitis due to cyanamide treatment. We administered cyanamide for alcoholis …
Oxacillin-induced granulocytopenia.
Fallon JA, Tall AR, Janis MG, Brauer MJ. Fallon JA, et al. Acta Haematol. 1978;59(3):163-70. doi: 10.1159/000207758. Acta Haematol. 1978. PMID: 416637
The development of granulocytopenia during oxacillin therapy is reported in 2 patients. In both cases the onset of granulocytopenia occurred 24 days after therapy was instituted with similar clinical presentations. ...Although sought for, leukoagglutinins cou …
The development of granulocytopenia during oxacillin therapy is reported in 2 patients. In both cases the onset of granulocytopeni …
Granulocyte transfusion therapy.
Schiffer CA. Schiffer CA. Curr Opin Hematol. 1999 Jan;6(1):3-7. doi: 10.1097/00062752-199901000-00002. Curr Opin Hematol. 1999. PMID: 9915547 Review.
Transfusions of granulocytes have been used for many decades to treat serious infections in patients with sustained periods of granulocytopenia. The benefit has been limited somewhat by the technical problems of obtaining adequate doses of granulocytes from normal donors a …
Transfusions of granulocytes have been used for many decades to treat serious infections in patients with sustained periods of granulocyt …
Fusidic acid adverse drug reactions.
Christiansen K. Christiansen K. Int J Antimicrob Agents. 1999 Aug;12 Suppl 2:S3-9. doi: 10.1016/s0924-8579(98)00068-5. Int J Antimicrob Agents. 1999. PMID: 10528781 Review.
A retrospective analysis showed this to be reversible and mainly associated with intravenous administration. Rarely reported side effects are granulocytopenia, thrombocytopenia and venous spasm. Skin reactions, including contact dermatitis, are uncommon. ...
A retrospective analysis showed this to be reversible and mainly associated with intravenous administration. Rarely reported side effects ar …
Antibacterial prophylaxis.
Cruciani M. Cruciani M. Int J Antimicrob Agents. 2000 Oct;16(2):123-5. doi: 10.1016/s0924-8579(00)00216-8. Int J Antimicrob Agents. 2000. PMID: 11053792 Review.
A number of prophylactic strategies have been used in order to reduce the risk of infection during severe granulocytopenia. The measures that have been investigated include isolation of the patient, granulocyte transfusion, active or passive immunisation, acceleration of g …
A number of prophylactic strategies have been used in order to reduce the risk of infection during severe granulocytopenia. The measu …
Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies.
Adkins JC, Peters DH, Markham A. Adkins JC, et al. Drugs. 1997 Jun;53(6):1005-37. doi: 10.2165/00003495-199753060-00007. Drugs. 1997. PMID: 9179529 Review.
The tolerability profile of fludarabine is similar to that of CAP, with the most common adverse events being granulocytopenia, thrombocytopenia, anaemia and infection. Alopecia and nausea/vomiting appear to be less frequent with fludarabine therapy than with CAP although t …
The tolerability profile of fludarabine is similar to that of CAP, with the most common adverse events being granulocytopenia, thromb …
1,588 results